EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:747559 |
| ChEBI Name | oxprenolol |
| Stars | |
| Definition | A racemate comprising equimolar amounts of (R)- and (S)-oxprenolol. |
| Last Modified | 13 April 2026 |
| Submitter | Adnan |
| Formula | C15H23NO3 |
| Net Charge | 0 |
| Average Mass | 265.353 |
| Monoisotopic Mass | 265.16779 |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Application: | beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| oxprenolol (CHEBI:747559) has part (R)-oxprenolol (CHEBI:747560) |
| oxprenolol (CHEBI:747559) has part (S)-oxprenolol (CHEBI:747561) |
| oxprenolol (CHEBI:747559) has role β-adrenergic antagonist (CHEBI:35530) |
| oxprenolol (CHEBI:747559) is a racemate (CHEBI:60911) |
| INNs | Source |
|---|---|
| oxprenolol | WHO MedNet |
| oxprenolol | WHO MedNet |
| oxprénolol | WHO MedNet |
| oxprenololum | WHO MedNet |
| Synonyms | Source |
|---|---|
| rac-(2R)-1-(propan-2-ylamino)-3-[2-(prop-2-en-1-yloxy)phenoxy]propan-2-ol | IUPAC |
| rac-oxprenolol | ChEBI |
| (RS)-oxprenolol | ChEBI |
| (±)-oxprenolol | ChEBI |
| racemic oxprenolol | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| DB01580 | DrugBank |
| HMDB0015520 | HMDB |
| Oxprenolol | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:6452-71-7 | CAS |